# Bug Fix and Risk Assessment Enhancements

## Date: February 20, 2026

## Summary

Fixed critical bug where all drug recommendations were shown regardless of drug selection, and enhanced the risk assessment system with detailed categories and dosage guidance.

---

## 🐛 Bug Fixed

### Issue: Drug Filtering Not Working
**Problem**: When users selected specific drugs (e.g., WARFARIN, CODEINE), the system would still show recommendations for ALL drugs in the database, not just the selected ones.

**Root Cause**: The PGx engine was filtering recommendations but not enforcing that ONLY selected drugs should be analyzed.

**Solution**: 
- Made `selected_drugs` parameter required in `analyze_variants()`
- Added strict filtering to skip any drug not in the selected list
- Added "Unknown" status for selected drugs with no variants detected
- Ensured report only contains recommendations for selected drugs

**Impact**: 
- ✅ Users now see ONLY the drugs they selected
- ✅ Clear feedback when no variant is detected for a selected drug
- ✅ Prevents confusion from irrelevant drug recommendations

---

## ✨ Enhancements

### 1. Detailed Risk Assessment Categories

**Old System**: Only 3 risk levels (high, moderate, low)

**New System**: 5 detailed risk categories:

| Category | Icon | Description | Use Case |
|----------|------|-------------|----------|
| **Toxicity** | 🛡️⚠️ | High risk of adverse effects | Drug causes severe side effects due to genetics |
| **Ineffective** | 🛡️❌ | Drug unlikely to work | Genetic variant prevents drug activation |
| **Adjust Dosage** | 💊 | Modified dosing required | Need to increase/decrease dose based on genetics |
| **Safe** | 🛡️✅ | Standard dosing recommended | No genetic concerns, use normally |
| **Unknown** | ❓ | No genetic variant detected | Standard dosing may be appropriate |

### 2. Dosage Guidance

**New Feature**: Specific dosage recommendations for each drug

**Examples**:
- **WARFARIN**: "Reduce initial dose by 25-50% (start 2.5-3.75mg daily). Monitor INR closely."
- **SIMVASTATIN**: "Reduce dose to 20mg daily (max 40mg). Monitor for muscle pain/weakness."
- **AZATHIOPRINE**: "Start with 30-70% of standard dose (0.75-1.5 mg/kg/day). Monitor CBC weekly for 4 weeks."
- **CODEINE**: "Do not use. Codeine will not be converted to morphine (active form)."
- **FLUOROURACIL**: "Do not use. High risk of severe neutropenia, mucositis, and death."

### 3. Enhanced UI Display

**Drug Recommendation Cards**:
- Larger, more prominent risk category badges
- Color-coded borders (red=toxicity, orange=ineffective, yellow=adjust, green=safe, gray=unknown)
- Dedicated "Dosage Guidance" section with blue highlight
- Improved typography and spacing
- Better visual hierarchy

**Summary Statistics**:
- New metrics: Drugs Analyzed, Toxicity Risk, Ineffective, Dosage Adjust
- Color-coded summary cards
- Removed legacy "High Risk" and "Moderate Risk" (replaced with specific categories)

### 4. Unknown Status Handling

**New Behavior**: When a drug is selected but no genetic variant is detected:

```json
{
  "drug": "WARFARIN",
  "gene": "CYP2C9",
  "diplotype": "Not detected",
  "phenotype": "Normal Metabolizer (presumed)",
  "risk_category": "unknown",
  "recommendation": "No genetic variants detected for CYP2C9. Standard dosing may be appropriate, but clinical judgment required.",
  "dosage_guidance": "Standard dosing recommended. Monitor patient response and adjust as needed."
}
```

**Benefits**:
- Users know the drug was analyzed
- Clear indication that no variant was found
- Guidance to use standard dosing with monitoring
- Prevents false negatives (thinking drug wasn't checked)

---

## 📊 Updated Data Model

### Backend Changes

#### PGx Engine (`pgx_engine.py`)
```python
# New risk categories
RISK_CATEGORIES = {
    "safe": "Safe - Standard dosing recommended",
    "adjust_dosage": "Adjust Dosage - Modified dosing required",
    "toxicity": "Toxicity Risk - High risk of adverse effects",
    "ineffective": "Ineffective - Drug unlikely to work",
    "unknown": "Unknown - No genetic variant detected"
}

# Drug-to-gene mapping
DRUG_GENE_MAP = {
    "CODEINE": "CYP2D6",
    "WARFARIN": "CYP2C9",
    "CLOPIDOGREL": "CYP2C19",
    "SIMVASTATIN": "SLCO1B1",
    "AZATHIOPRINE": "TPMT",
    "FLUOROURACIL": "DPYD"
}
```

#### Updated CPIC Rules
Each rule now includes:
- `risk_category`: New detailed category
- `dosage_guidance`: Specific dosing instructions
- Updated drug names to uppercase for consistency

#### Schemas (`schemas.py`)
```python
class DrugRecommendationOut(BaseModel):
    drug: str
    gene: str
    diplotype: str
    phenotype: str
    risk_category: str  # NEW
    risk_level: str
    recommendation: str
    dosage_guidance: str  # NEW
    guideline: str
    evidence: str
    alternatives: List[str]

class ReportSummary(BaseModel):
    total_variants: int
    drugs_analyzed: int  # NEW
    clinically_relevant: int
    toxicity_risk: int  # NEW
    ineffective_risk: int  # NEW
    dosage_adjustment: int  # NEW
    safe: int  # NEW
    unknown: int  # NEW
    high_risk_drugs: int  # Legacy
    moderate_risk_drugs: int  # Legacy

class ClinicalReportOut(BaseModel):
    # ... existing fields ...
    selected_drugs: List[str]  # NEW - shows which drugs were analyzed
```

### Frontend Changes

#### Types (`types.ts`)
```typescript
export type RiskCategory = "safe" | "adjust_dosage" | "toxicity" | "ineffective" | "unknown";

export interface DrugRecommendation {
  // ... existing fields ...
  riskCategory: RiskCategory;  // NEW
  dosageGuidance: string;  // NEW
}

export interface ClinicalReport {
  // ... existing fields ...
  selectedDrugs: string[];  // NEW
  summary: {
    // ... existing fields ...
    drugsAnalyzed: number;  // NEW
    toxicityRisk: number;  // NEW
    ineffectiveRisk: number;  // NEW
    dosageAdjustment: number;  // NEW
    safe: number;  // NEW
    unknown: number;  // NEW
  };
}
```

#### Components
- **DrugRecommendationCard**: Enhanced with risk category colors, dosage guidance section
- **ReportViewer**: Updated summary cards with new metrics

---

## 🧪 Testing

### Test Case 1: Single Drug with Variant
**Input**: 
- VCF with CYP2C9 variant (rs1799853)
- Selected drug: WARFARIN

**Expected Output**:
```json
{
  "selected_drugs": ["WARFARIN"],
  "recommendations": [
    {
      "drug": "WARFARIN",
      "gene": "CYP2C9",
      "risk_category": "adjust_dosage",
      "dosage_guidance": "Reduce initial dose by 25-50%..."
    }
  ],
  "summary": {
    "drugs_analyzed": 1,
    "dosage_adjustment": 1,
    "toxicity_risk": 0,
    "ineffective_risk": 0
  }
}
```

### Test Case 2: Single Drug without Variant
**Input**:
- VCF without CYP2C9 variant
- Selected drug: WARFARIN

**Expected Output**:
```json
{
  "selected_drugs": ["WARFARIN"],
  "recommendations": [
    {
      "drug": "WARFARIN",
      "gene": "CYP2C9",
      "diplotype": "Not detected",
      "risk_category": "unknown",
      "dosage_guidance": "Standard dosing recommended..."
    }
  ],
  "summary": {
    "drugs_analyzed": 1,
    "unknown": 1
  }
}
```

### Test Case 3: Multiple Drugs Mixed Results
**Input**:
- VCF with CYP2C9 variant (rs1799853) and DPYD variant (rs3918290)
- Selected drugs: WARFARIN, CODEINE, FLUOROURACIL

**Expected Output**:
```json
{
  "selected_drugs": ["WARFARIN", "CODEINE", "FLUOROURACIL"],
  "recommendations": [
    {
      "drug": "FLUOROURACIL",
      "risk_category": "toxicity"  // Sorted first (highest risk)
    },
    {
      "drug": "WARFARIN",
      "risk_category": "adjust_dosage"
    },
    {
      "drug": "CODEINE",
      "risk_category": "unknown"  // No variant found
    }
  ],
  "summary": {
    "drugs_analyzed": 3,
    "toxicity_risk": 1,
    "dosage_adjustment": 1,
    "unknown": 1
  }
}
```

### Test Case 4: Bug Fix Verification
**Input**:
- VCF with multiple variants
- Selected drug: WARFARIN only

**Expected Output**:
- ✅ ONLY WARFARIN recommendation shown
- ❌ NO recommendations for CODEINE, CLOPIDOGREL, etc.
- ✅ Report clearly shows `selected_drugs: ["WARFARIN"]`

---

## 🎨 UI Examples

### Risk Category Display

**Toxicity Risk** (Red):
```
┌─────────────────────────────────────────────┐
│ 🛡️⚠️ FLUOROURACIL    [Toxicity Risk]       │
│ DPYD · Poor Metabolizer                     │
├─────────────────────────────────────────────┤
│ High risk of adverse effects - avoid or    │
│ use extreme caution                         │
│                                             │
│ 💊 DOSAGE GUIDANCE                          │
│ Do not use. High risk of severe            │
│ neutropenia, mucositis, and death.          │
└─────────────────────────────────────────────┘
```

**Adjust Dosage** (Yellow):
```
┌─────────────────────────────────────────────┐
│ 💊 WARFARIN    [Adjust Dosage]              │
│ CYP2C9 · Intermediate Metabolizer           │
├─────────────────────────────────────────────┤
│ Modified dosing required based on genetics  │
│                                             │
│ 💊 DOSAGE GUIDANCE                          │
│ Reduce initial dose by 25-50% (start       │
│ 2.5-3.75mg daily). Monitor INR closely.     │
└─────────────────────────────────────────────┘
```

**Unknown** (Gray):
```
┌─────────────────────────────────────────────┐
│ ❓ CODEINE    [Unknown]                     │
│ CYP2D6 · Normal Metabolizer (presumed)      │
├─────────────────────────────────────────────┤
│ No genetic variant detected - standard      │
│ dosing may be appropriate                   │
│                                             │
│ 💊 DOSAGE GUIDANCE                          │
│ Standard dosing recommended. Monitor        │
│ patient response and adjust as needed.      │
└─────────────────────────────────────────────┘
```

---

## 📈 Impact

### Before Fix
- ❌ Users confused by seeing all drugs
- ❌ No way to know if drug was actually analyzed
- ❌ Generic risk levels (high/moderate/low)
- ❌ No specific dosage guidance

### After Fix
- ✅ Only selected drugs shown
- ✅ Clear "Unknown" status when no variant found
- ✅ Detailed risk categories (toxicity, ineffective, adjust, safe, unknown)
- ✅ Specific dosage recommendations
- ✅ Better visual hierarchy and color coding
- ✅ Enhanced clinical decision support

---

## 🔄 Migration Notes

### Backward Compatibility
- Legacy fields (`high_risk_drugs`, `moderate_risk_drugs`) still included in summary
- Old `risk_level` field maintained alongside new `risk_category`
- Existing API consumers will continue to work

### Breaking Changes
- `selected_drugs` parameter now REQUIRED in `analyze_variants()`
- Analysis will fail if no drugs specified (prevents accidental full analysis)

---

## 📝 Updated Documentation

Files updated:
1. `backend/app/services/pgx_engine.py` - Core analysis logic
2. `backend/app/schemas.py` - API response schemas
3. `src/lib/types.ts` - Frontend type definitions
4. `src/components/DrugRecommendationCard.tsx` - UI display
5. `src/components/ReportViewer.tsx` - Summary statistics

New documentation:
- `BUG_FIX_AND_ENHANCEMENTS.md` (this file)

---

## 🚀 Deployment

### Backend
```bash
cd pharmaguard-clinical-insights-main/backend
python -m uvicorn app.main:app --host 0.0.0.0 --port 8000 --reload
```

### Frontend
```bash
cd pharmaguard-clinical-insights-main
npm run dev
```

### Verification
1. Select a single drug (e.g., WARFARIN)
2. Upload VCF file
3. Verify ONLY WARFARIN appears in results
4. Check for "Unknown" status if no variant found
5. Verify dosage guidance is displayed
6. Check risk category colors and badges

---

## 🎯 Key Takeaways

1. **Bug Fixed**: Drug filtering now works correctly - only selected drugs are analyzed and shown
2. **Enhanced Risk Assessment**: 5 detailed categories instead of 3 generic levels
3. **Dosage Guidance**: Specific, actionable dosing recommendations for clinicians
4. **Unknown Status**: Clear feedback when no genetic variant is detected
5. **Better UX**: Improved visual design with color coding and prominent badges
6. **Clinical Value**: More actionable information for healthcare providers

---

## 📞 Support

For questions or issues:
1. Check API documentation: http://localhost:8000/docs
2. Review this document
3. Check backend logs for errors
4. Verify drug selection in request payload

---

**Status**: ✅ COMPLETED AND TESTED
**Version**: 2.0.0
**Date**: February 20, 2026
